Ottensmeier Chh.

发表

DOC-MEK: A double-blind randomized phase II trial of docetaxel with or without selumetinib (AZD6244; ARRY-142886) in wt BRAF advanced melanoma

R. Plummer, M. Churchman, P. Nathan, 2013 .